Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jul;63(7):2762–2765. doi: 10.1128/iai.63.7.2762-2765.1995

Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.

V J Levenson 1, C P Mallett 1, T L Hale 1
PMCID: PMC173369  PMID: 7790095

Abstract

Nucleoprotein subcellular (NPS) vaccine, consisting of ribosome-bound O polysaccharide, was prepared from avirulent Shigella sonnei. NPS vaccine was tested for safety and protective activity in the mouse intranasal challenge model of Shigella infection. The vaccine was nontoxic when injected in doses up to 10,000 micrograms, and a single subcutaneous injection of as little as 0.1 micrograms gave significant protection against a lethal intranasal challenge with S. sonnei. These data demonstrate the induction of local protective immunity by parenteral immunization, support the concept of the ribosome as a potent vaccine vector, and give additional evidence for the protective activity of the NPS vaccine against Shigella infection.

Full Text

The Full Text of this article is available as a PDF (205.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belkin Z. P., Levenson V. I. Giperchuvstvitel'nost' zamedlennogo tipa u myshei, immunizirovannykh ribosomal'noi vaktsinoi Shigella sonnei. Zh Mikrobiol Epidemiol Immunobiol. 1986 Dec;(12):56–59. [PubMed] [Google Scholar]
  2. Boutorine A. S., Kostina E. V. Reversible covalent attachment of cholesterol to oligodeoxyribonucleotides for studies of the mechanisms of their penetration into eucaryotic cells. Biochimie. 1993;75(1-2):35–41. doi: 10.1016/0300-9084(93)90022-k. [DOI] [PubMed] [Google Scholar]
  3. Braum W. RNAs as amplifiers of specific signals in immunity. Ann N Y Acad Sci. 1973 May 31;207:17–28. doi: 10.1111/j.1749-6632.1973.tb47473.x. [DOI] [PubMed] [Google Scholar]
  4. Charachon R., Lavillauroy P. J., Fumex J. P. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology. Arzneimittelforschung. 1980;30(1A):214–220. [PubMed] [Google Scholar]
  5. Chernokhvostova E. V., Lyubinskaya M. M., Belkin Z. P., Levenson V. I. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine. Int Arch Allergy Appl Immunol. 1990;92(3):265–267. doi: 10.1159/000235187. [DOI] [PubMed] [Google Scholar]
  6. Collett M. S. The development of biosynthetic vaccines. Adv Vet Sci Comp Med. 1989;33:109–172. doi: 10.1016/b978-0-12-039233-9.50008-1. [DOI] [PubMed] [Google Scholar]
  7. Eisenstein T. K. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun. 1975 Aug;12(2):364–377. doi: 10.1128/iai.12.2.364-377.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Formal S. B., Maenza R. M., Austin S., LaBrec E. H. Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med. 1967 Jun;125(2):347–349. doi: 10.3181/00379727-125-32087. [DOI] [PubMed] [Google Scholar]
  9. Friedman H. RNA modulating specific and nonspecific immune responses. Ann N Y Acad Sci. 1979;332:187–195. doi: 10.1111/j.1749-6632.1979.tb47112.x. [DOI] [PubMed] [Google Scholar]
  10. Geselowitz D. A., Neckers L. M. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res Dev. 1992 Spring;2(1):17–25. doi: 10.1089/ard.1992.2.17. [DOI] [PubMed] [Google Scholar]
  11. Gonggrijp R., Volleberg M. P., Lemmens P. J., van Boven C. P. Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa. Infect Immun. 1981 Mar;31(3):896–905. doi: 10.1128/iai.31.3.896-905.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodarzi G., Watabe M., Watabe K. Binding of oligonucleotides to cell membranes at acidic pH. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1343–1351. doi: 10.1016/0006-291x(91)92086-y. [DOI] [PubMed] [Google Scholar]
  13. Gregory R. L. Microbial ribosomal vaccines. Rev Infect Dis. 1986 Mar-Apr;8(2):208–217. doi: 10.1093/clinids/8.2.208. [DOI] [PubMed] [Google Scholar]
  14. HIGGINS A. R., FLOYD T. M., KADER M. A. Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment. Am J Trop Med Hyg. 1955 Mar;4(2):281–288. [PubMed] [Google Scholar]
  15. Hale T. L., Keren D. F. Pathogenesis and immunology in shigellosis: applications for vaccine development. Curr Top Microbiol Immunol. 1992;180:117–137. doi: 10.1007/978-3-642-77238-2_6. [DOI] [PubMed] [Google Scholar]
  16. Krieg A. M., Gmelig-Meyling F., Gourley M. F., Kisch W. J., Chrisey L. A., Steinberg A. D. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res Dev. 1991 Summer;1(2):161–171. doi: 10.1089/ard.1991.1.161. [DOI] [PubMed] [Google Scholar]
  17. Levenson V. I., Chernokhvostova E. V., Lyubinskaya M. M., Salamatova S. A., Dzhikidze E. K., Stasilevitch Z. K. Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory. Int Arch Allergy Appl Immunol. 1988;87(1):25–31. doi: 10.1159/000234644. [DOI] [PubMed] [Google Scholar]
  18. Levenson V. I., Dzhikidze E. K., Stasilevich Z. K., Kavtaradze K. N., Subbotina Iu L. Ispytanie protektivnoi aktivnosti ribosomal'noi vaktsiny Zonne na obez'ianakh. Vestn Akad Med Nauk SSSR. 1986;(3):69–72. [PubMed] [Google Scholar]
  19. Levenson V. I., Egorova T. P., Belkin Z. P., Fedosova V. G., Subbotina J. L., Rukhadze E. Z., Dzhikidze E. K., Stassilevich Z. K. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun. 1991 Oct;59(10):3610–3618. doi: 10.1128/iai.59.10.3610-3618.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levenson V. I., Egorova T. P. Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept. Res Microbiol. 1990 Jul-Aug;141(6):707–720. doi: 10.1016/0923-2508(90)90065-x. [DOI] [PubMed] [Google Scholar]
  21. Levenson V. I., Gorach G. G., Dadashev S. Ia, Rukhadze E. Z. Vydelenie i ochistka bakterial'nykh ribosom ot éndotoksina s pomoshch'iu poliétilenglikolia. Zh Mikrobiol Epidemiol Immunobiol. 1984 May;(5):20–25. [PubMed] [Google Scholar]
  22. Levenson V. I., Rukhadze E. Z., Fedosova V. G., Dzhikidze E. K., Stasilevich Z. K. Biologicheskie svoistva ribosomal'noi vaktsiny iz S. sonnei, poluchennoi metodom fraktsionirovaniia poliétilenglikolem. Zh Mikrobiol Epidemiol Immunobiol. 1984 Nov;(11):77–81. [PubMed] [Google Scholar]
  23. Lindberg A. A., Pál T. Strategies for development of potential candidate Shigella vaccines. Vaccine. 1993;11(2):168–179. doi: 10.1016/0264-410x(93)90014-o. [DOI] [PubMed] [Google Scholar]
  24. Lynn M., Katz M. A., Santucci T. F., Jr Naturally occurring antibodies in human sera that react with Haemophilus influenzae type b ribosomal vaccine. J Clin Microbiol. 1983 May;17(5):844–847. doi: 10.1128/jcm.17.5.844-847.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mallett C. P., VanDeVerg L., Collins H. H., Hale T. L. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine. 1993;11(2):190–196. doi: 10.1016/0264-410x(93)90016-q. [DOI] [PubMed] [Google Scholar]
  26. Misfeldt M. L., Johnson W. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium. Infect Immun. 1977 Jul;17(1):98–104. doi: 10.1128/iai.17.1.98-104.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Phillips M., Brogden K. A. Physical and morphological characteristics of eucaryotic ribosomes and lipopolysaccharide complexes. Infect Immun. 1987 Sep;55(9):2047–2051. doi: 10.1128/iai.55.9.2047-2051.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Phillips M., Eisenstein T. K., Meissler J. Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes. Infect Immun. 1985 Apr;48(1):244–247. doi: 10.1128/iai.48.1.244-247.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Robbins J. B., Chu C., Schneerson R. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin Infect Dis. 1992 Aug;15(2):346–361. doi: 10.1093/clinids/15.2.346. [DOI] [PubMed] [Google Scholar]
  30. Robbins J. B., Chu C., Watson D. C., Szu S. C., Daniels E. M., Lowe C. U., Schneerson R. O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases. Rev Infect Dis. 1991 Mar-Apr;13 (Suppl 4):S362–S365. doi: 10.1093/clinids/13.supplement_4.s362. [DOI] [PubMed] [Google Scholar]
  31. Salamatova S. A., Sukhoroslova L. I., Chernokhvostova E. V., Levenson V. I. Opredelenie v sliune IgA-antitel k ribosomam shigell dlia diagnostiki dizenterii. Zh Mikrobiol Epidemiol Immunobiol. 1991 Jun;(6):59–62. [PubMed] [Google Scholar]
  32. Sansonetti P. J. Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev Infect Dis. 1991 Mar-Apr;13 (Suppl 4):S285–S292. doi: 10.1093/clinids/13.supplement_4.s285. [DOI] [PubMed] [Google Scholar]
  33. Shikhman A. R. Isplo'zovanie immunofermentnogo analiza dlia otsenki spetsifich-nosti raspoznavaniia antitelami antigennykh determinant ribosom streptokokka gruppy A. Zh Mikrobiol Epidemiol Immunobiol. 1985 Jul;(7):52–55. [PubMed] [Google Scholar]
  34. Taylor D. N., Trofa A. C., Sadoff J., Chu C., Bryla D., Shiloach J., Cohen D., Ashkenazi S., Lerman Y., Egan W. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun. 1993 Sep;61(9):3678–3687. doi: 10.1128/iai.61.9.3678-3687.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. YOUMANS A. S., YOUMANS G. P. IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol. 1965 May;89:1291–1298. doi: 10.1128/jb.89.5.1291-1298.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES